Upcoming Events
Log In
Pricing
Free Trial

Membranous Septal Length

HIDE
PrevNext

0:00

Okay, next we're gonna, in this video talk about membranous septal length.

0:05

And so what's the rationale behind membranous septal length? Why do we care?

0:10

Um, well,

0:11

heart block turns out is one of the most frequent complications of tavr. Uh,

0:16

and it's really common for patients to get a new left bundle branch block, um,

0:20

approximately 13 to 28% of patients. And then even a new heart block,

0:24

which requires pacemaker, uh, in around four to 20% of patients depending on,

0:29

um, the, the study you look at, uh,

0:32

and it turns out that there are multiple risk factors for heart block, um,

0:36

right bundle branch block, um, before the tavr, low implantation,

0:42

short membrane septal length eccentric, L V O T and annular calcifications.

0:47

So all these factors are important. The annular calcifications,

0:50

we're actually gonna talk about that in a separate video. Um,

0:53

and then these two,

0:54

low implantation and short membrane septal length are kind of related. Um, and,

0:58

and it turns out that, um,

1:00

we can measure membrane septal length and provide that additional information,

1:05

um, to our interventional colleagues, um,

1:07

that may help them determine which patients are at higher risk of need for

1:11

pacemaker. So I just wanna note, um, before moving on,

1:14

that this is not a routine measurement that's done. It's something that's,

1:19

I would say not part of the, the standard of care yet. Um, but I,

1:23

I certainly wanna include it in this series because I think it may be something

1:26

that we need to start doing in the future. Um, you know,

1:29

depending on how the data evolves. So here's a study that came out recently.

1:34

This was actually a trial, um,

1:36

where they were trying to minimize permanent pacemaker implantation after

1:41

tavr, um, by looking at membranous septal length.

1:43

And the concept here is that the membranous septum is this little bit of tissue

1:48

that lives right below the aortic valve and before the muscular part of the

1:51

septum and the short of the membrane septal length,

1:55

the more risk that that device when it's implanted is gonna, uh,

1:59

basically impact the conduction tissue,

2:01

which lives in this basal septal area right here. Um,

2:05

so this is actually a case, um, from our, uh,

2:07

institution of a patient with a short member septal length.

2:11

And then you can see clearly that after the TAVR device was placed, um,

2:15

the device is sitting below the level of the membranous septum. Um,

2:19

and this patient did have a left bundle branch block after tavr. Fortunately,

2:23

they didn't need a pacer. Um, but nonetheless,

2:25

that's an outcome you'd like to avoid. So, uh, in this study,

2:30

they looked at the membranous septal length and they found that the bulk of

2:35

their patients who needed pacers had a really short membranous septum less than

2:39

five millimeters.

2:40

And then what they did is prospectively in a hundred patients,

2:44

they measured the membrane septal length,

2:46

and they tried their best to position the device at a depth less than the

2:50

membrane septal length. So try to avoid those deep implantations,

2:54

and sure enough that they found that if they avoid those deep implantations,

2:57

that the new pacemaker

2:59

Rate reduced from around 10% to 3%, uh,

3:02

if they were paying attention to the membrane septal length.

3:05

So this is some of the, you know, initial data that,

3:07

that helps us think that this, you know, might be an important measure to watch,

3:12

uh, out for. And, and again, it's not completely established yet, um,

3:16

but it's something that, you know, to be aware of and,

3:19

and maybe more important in the future. So just to sum up,

3:22

a membrane septal length less than eight millimeters, um,

3:25

is generally considered higher risk.

3:27

That information actually comes from this reference down here. That's a,

3:31

a summary statement, um, about, um, evaluation of, uh,

3:34

pre TAVR CT scans. Um, so currently, like I mentioned,

3:38

it's not standard component of TAVR reports. However,

3:40

it might be an important variable, uh,

3:42

in the future as further data becomes available.

Report

Faculty

Stefan Loy Zimmerman, MD

Associate Professor of Radiology and Radiological Science

Johns Hopkins Medicine Department of Radiology and Radiological Science

Tags

Vascular

Idiopathic

Congenital

Cardiac valves

Cardiac Chambers

Cardiac

CTA

CT

Acquired/Developmental